According to IMARC Group’s latest report, titled “Hemostats Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the global hemostats market to continue its moderate growth during the next five years.
Hemostats are the medical devices that compress blood vessels and reduce the flow of blood or other fluids. They are majorly used during surgical procedures to control bleeding in patients. Hemostatic agents enable faster wound healing, reduce operative time, enhance patient’s recovery, and help in treating anticoagulated patients. Various surgical hemostatic agents are available based on different compositions, immunogenicity, and the mechanism of action, application and adherence.
Request for a free sample copy of this report: https://www.imarcgroup.com/hemostats-market/requestsample
Market Trends
The growing prevalence of chronic blood-related disorders, cesarean deliveries, fatal injuries, organ surgeries, etc., is primarily driving the demand for hemostats to reduce blood loss. Moreover, several technological advancements have led to the development of absorbable adjunctive hemostats that help in controlling disruptive bleeding more efficiently than the conventional devices. Additionally, the growing utilization of nano- and micro-materials for treating uncontrolled hemorrhage and internal bleeding is also augmenting the market growth. Several manufacturers have introduced advanced laparoscopic hemostats to enhance surgical operations quality and facilitate less invasive procedures, which are further expected to drive the global market.
Hemostats 2020-2025 Analysis and Segmentation:
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Arch Therapeutics Inc., Baxter International Inc., B. Braun Melsungen Aktiengesell, C. R. Bard Inc., GELITA MEDICAL GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Pfizer Inc., Stryker Corporation, Teleflex Incorporated and Z-Medica LLC.
Breakup by Product:
- Thrombin Based
- Combination Based
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
Breakup by Application:
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
Breakup by Formulation:
- Matrix and Gel Hemostats
- Sheet and Pad Hemostats
- Sponge Hemostats
- Powder Hemostats
Explore full report with table of contents: https://www.imarcgroup.com/hemostats-market
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
